Sign in

Research summary ·

Age-Dependent Progression of Neurological Involvement in PRPP Deficiency: Insights from a Four-Generation Family and Systematic Review.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This review looked at a rare problem in the PRPS1 gene. Changes in this gene can cause deafness and nerve damage. In the past, doctors saw these as separate diseases. The team described one family with this gene change. They also searched past reports in a set, careful way. In total, they found 19 people with a confirmed gene change. They then timed when each kind of problem began.

What they found

Hearing loss showed up first, with a median of 0 years. Nerve problems came later, with a median of 3 years. Eye signs came after that, at a median of 11.5 years. The median delay in symptoms was 3 years, up to 19. For the first patient in the family, diagnosis took 15 years.

What it means for patients

The authors see DFNX1, CMTX5 and Arts syndrome as one linked disease range. They think some body parts suffer more from a lack of cell fuel. This could explain why problems appear at different times. They note that some treatments help little once nerves are badly harmed. So they say spotting the disease early matters a lot. Then treatment might start before nerve damage can no longer be undone.

Why it is not certain yet

The review is based on only 19 people. The link to a lack of cell fuel is the authors' idea. The abstract does not show that this idea was tested. It also does not give results from treating these people. A review can only be as good as the studies in it.

Source

Age-Dependent Progression of Neurological Involvement in PRPP Deficiency: Insights from a Four-Generation Family and Systematic Review.

PubMed · PMID 42650830

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Charcot-Marie-Tooth disease publications